News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 73–108
- Matches
- 233
- Sources here
- 14
- Companies here
- 10
Active search
233 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Earnings call transcript: Oxford Square Capital tops Q2 2026 EPS view
Oxford Square Capital Corp. Q2 2026 Earnings Call Summary - Moby Strategic Performance and Market Context Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. …
Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended June 30, 2026 and Declaration of Distributions on Common Stock for the Months Ending October 31, November 30, and December 31, 2026
GREENWICH, Conn., July 31, 2026 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQG) (NasdaqGS: OXSQH) (the “Company,” “we,” “us” or “our”) announced today its financial results and related information for the quarter ended June 30, 2026. ·On July 29, 2026, our …
Oxford Industries, Inc. (NYSE:OXM) Receives Average Recommendation of "Reduce" from Analysts
Oxford Industries, Inc. (NYSE:OXM) has received an average "Reduce" recommendation from eight analysts, with one rating it a "sell" and seven a "hold." The average twelve-month price target for the stock is $40.00. The company recently reported earnings that topped consensus estimates, but its …
X4 Pharmaceuticals Inc (XFOR) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of X4 Pharmaceuticals Inc (XFOR), focusing on its support and resistance levels, key indicators, and moving averages. The stock is currently trading between a resistance level of 4.45 and a support level of 3.53, suggesting potential for range-bound …
Arrowstreet Capital Limited Partnership Sells 67,551 Shares of Oxford Industries, Inc. $OXM
Arrowstreet Capital Limited Partnership reduced its stake in Oxford Industries, Inc. (NYSE:OXM) by 13.7% in the first quarter, selling 67,551 shares and now owning 424,336 shares valued at $16.34 million. Other institutional investors have also adjusted their positions in OXM, while CEO Thomas Caldecot …
X4 Pharmaceuticals Inc (XFOR) Institutional Confidence
X4 Pharmaceuticals Inc (XFOR) has an institutional shareholding score of 3.00, placing it 92nd out of 155 in the Pharmaceuticals industry. The institutional shareholding proportion is 9.67%, marking a significant quarter-over-quarter decrease of 89.43%. While the largest reported shareholder, Bill Nygren | OAKMX, shows …
Oxford Industries Inc (OXM) Risk Assessment: Volatility, Financial Risk & Investment Risk
This article provides a risk assessment for Oxford Industries Inc (OXM), detailing its current score of 4.87, ranking 22 out of 36 in the Textiles & Apparel industry. It highlights the company's beta of 1.03, indicating higher volatility than the S&P 500, and presents …
X4 Pharmaceuticals Inc (XFOR) Financial Health: Profitability & Balance Sheet Analysis
X4 Pharmaceuticals Inc (XFOR) currently holds a financial score of 7.36, placing it 116th out of 155 in the Pharmaceuticals industry, indicating robust financial status but low operating efficiency. The company's latest quarterly revenue significantly decreased by 90.60% year-over-year to $2.71M, and its net …
Oxford Industries Inc (OXM) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Oxford Industries Inc (OXM), showing its current price momentum score as 4.49, ranking 6th in the Textiles & Apparel industry. It highlights the stock trading between a resistance level of 44.52 and a support level of 35.81, …
Oxford Lane Capital Corp. CAL NT 31 declares $0.1718 dividend
* Oxford Lane Capital Corp. CAL NT 31 (OXLCM [https://seekingalpha.com/symbol/OXLCM]) declares $0.1718/share monthly dividend [https://seekingalpha.com/pr/20597202-oxford-lane-capital-corp-announces-net-asset-value-and-selected-financial-results-for-the]. * Forward yield [https://seekingalpha.com/symbol/OXLCM/dividends/yield?source=news_bullet] 8.28% * Payable Sept. 30; for shareholders of record Sept. 16; ex-div Sept. 16. * Payable Oct. 30; for shareholders of record Oct. 16; ex-div …
Oxford Lane Capital Corp. CAL NT 29 declares $0.125 dividend
* Oxford Lane Capital Corp. CAL NT 29 (OXLCO [https://seekingalpha.com/symbol/OXLCO]) declares $0.125/share monthly dividend [https://seekingalpha.com/pr/20597202-oxford-lane-capital-corp-announces-net-asset-value-and-selected-financial-results-for-the], in line with previous. * Forward yield [https://seekingalpha.com/symbol/OXLCO/dividends/yield?source=news_bullet] 6.25% * Payable Sept. 30; for shareholders of record Sept. 16; ex-div Sept. 16. * Payable Oct. 30; for shareholders of …
Oxford Industries Inc (OXM) Institutional Confidence
Oxford Industries Inc (OXM) has an institutional shareholding score of 10.00, ranking 1st in the Textiles & Apparel industry. The institutional shareholding proportion increased by 16.71% quarter-over-quarter to 125.15%. HOTCHKIS & WILEY is the largest institutional shareholder, holding 1.26% of outstanding shares.
Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results for the First Fiscal Quarter, and Declaration of Common Stock Distributions for the Months Ending October, November, and December 2026
GREENWICH, Conn., July 28, 2026 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (NasdaqGS: OXLCI) (NasdaqGS: OXLCG) (NasdaqGS: OXLCM) ("Oxford Lane," the "Company," "we," "us" or "our") announced today the following financial results and related …
Sharemaestro market context Trend signal active 28 weeks +3.2% · Next-week setup positive 59.3%XFOR|X4 Pharmaceuticals Inc|Price:4.000|Chg%:+0.070
TradingKey provides a comprehensive stock analysis for X4 Pharmaceuticals Inc (XFOR), highlighting its strong fundamentals, high growth potential, and relatively fair valuation. The company is in a growing phase with a lead clinical candidate, mavorixafor, and has received a "Strong Buy" rating from analysts …